Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2009 1
2011 1
2013 2
2015 2
2016 2
2017 2
2018 2
2020 1
2021 1
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Natural products for male androgenetic alopecia.
Gupta AK, Talukder M, Bamimore MA. Gupta AK, et al. Dermatol Ther. 2022 Apr;35(4):e15323. doi: 10.1111/dth.15323. Epub 2022 Jan 27. Dermatol Ther. 2022. PMID: 35044013 Review.
The US FDA approved topical minoxidil and oral finasteride to treat AGA. Topical minoxidil requires a long-term application to observe improvement; oral finasteride may cause undesirable side effects. ...Physicians may also suggest natural produ …
The US FDA approved topical minoxidil and oral finasteride to treat AGA. Topical minoxidil requires a long-term …
A Systematic Review of Topical Finasteride in the Treatment of Androgenetic Alopecia in Men and Women.
Lee SW, Juhasz M, Mobasher P, Ekelem C, Mesinkovska NA. Lee SW, et al. J Drugs Dermatol. 2018 Apr 1;17(4):457-463. J Drugs Dermatol. 2018. PMID: 29601622 Free PMC article. Review.
INTRODUCTION: Currently, only topical minoxidil (MNX) and oral finasteride (FNS) are approved by the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of androgenetic alopecia. Although FNS is efficacious for hair re …
INTRODUCTION: Currently, only topical minoxidil (MNX) and oral finasteride (FNS) are approved by the Food and Drug Administrat …
Topical Finasteride: A Comprehensive Review of Androgenetic Alopecia Management for Men and Women.
Keerti A, Madke B, Keerti A, Lopez MJC, Lirio FS. Keerti A, et al. Cureus. 2023 Sep 9;15(9):e44949. doi: 10.7759/cureus.44949. eCollection 2023 Sep. Cureus. 2023. PMID: 37818522 Free PMC article. Review.
Only topical minoxidil and oral finasteride are now approved by the Food and Drug Administration and the European Medicines Agency for the treatment of androgenetic alopecia. Despite being effective for hair regeneration, systemic use of finasteride is …
Only topical minoxidil and oral finasteride are now approved by the Food and Drug Administration and the European Medicines Ag …
Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version.
Manabe M, Tsuboi R, Itami S, Osada SI, Amoh Y, Ito T, Inui S, Ueki R, Ohyama M, Kurata S, Kono T, Saito N, Sato A, Shimomura Y, Nakamura M, Narusawa H, Yamazaki M; Drafting Committee for the Guidelines for the Diagnosis and Treatment of Male- and Female-Pattern Hair Loss. Manabe M, et al. J Dermatol. 2018 Sep;45(9):1031-1043. doi: 10.1111/1346-8138.14470. Epub 2018 Jun 4. J Dermatol. 2018. PMID: 29863806
Male-pattern hair loss (MPHL, androgenetic alopecia) is a slowly progressive form of alopecia which begins after puberty. ...Thus, here we report a revised version of the 2010 guidelines aimed at both MPHL and FPHL. In these guidelines, finasteride 1 mg daily …
Male-pattern hair loss (MPHL, androgenetic alopecia) is a slowly progressive form of alopecia which begins after puberty. ...T …
Oral Finasteride Presents With Sexual-Unrelated Withdrawal in Long-Term Treated Androgenic Alopecia in Men.
Perez-Mora N, Velasco C, Bermüdez F. Perez-Mora N, et al. Skinmed. 2015 May-Jun;13(3):179-83. Skinmed. 2015. PMID: 26380503
Side effects associated with oral finasteride (FT) (1 mg/d) and topical 5% minoxidil (M5) have been previously described. The authors have evaluated long-term adverse effects and causes of long-term therapy withdrawal in patients with androgenic alo …
Side effects associated with oral finasteride (FT) (1 mg/d) and topical 5% minoxidil (M5) have been previously described. The …
Multi-therapies in androgenetic alopecia: review and clinical experiences.
Rossi A, Anzalone A, Fortuna MC, Caro G, Garelli V, Pranteda G, Carlesimo M. Rossi A, et al. Dermatol Ther. 2016 Nov;29(6):424-432. doi: 10.1111/dth.12390. Epub 2016 Jul 18. Dermatol Ther. 2016. PMID: 27424565 Review.
Androgenetic alopecia (AGA) is a genetically determined progressive hair-loss condition which represents the most common cause of hair loss in men. The use of the medical term androgenetic alopecia reflects current knowledge about the important role of androg …
Androgenetic alopecia (AGA) is a genetically determined progressive hair-loss condition which represents the most common cause of hai …
Nanostructured Drug Delivery Systems for Targeting 5-α-Reductase Inhibitors to the Hair Follicle.
Tampucci S, Paganini V, Burgalassi S, Chetoni P, Monti D. Tampucci S, et al. Pharmaceutics. 2022 Jan 26;14(2):286. doi: 10.3390/pharmaceutics14020286. Pharmaceutics. 2022. PMID: 35214018 Free PMC article. Review.
Androgenetic alopecia is a multifactorial condition characterized by noticeable hair loss, affecting both men and women and representing a debilitating and chronic disorder that considerably affects the quality of life. Available topical treatments based on minoxidil …
Androgenetic alopecia is a multifactorial condition characterized by noticeable hair loss, affecting both men and women and represent …
Platelet-Rich Plasma in Androgenetic Alopecia: Is It Really Worth the Hype?
Agarwal P, Gajjar KM, Jagati A, Chaudhari SV, Rathod SP. Agarwal P, et al. Int J Trichology. 2023 May-Jun;15(3):98-104. doi: 10.4103/ijt.ijt_31_21. Epub 2023 Dec 1. Int J Trichology. 2023. PMID: 38179010 Free PMC article.
INTRODUCTION: Androgenetic alopecia (AGA) is defined as progressive, patterned hair loss that occurs as a result of androgen-mediated conversion of terminal hairs to vellus hairs. ...Food and Drug Administration-approved treatments for AGA include oral finasteride a …
INTRODUCTION: Androgenetic alopecia (AGA) is defined as progressive, patterned hair loss that occurs as a result of androgen-mediated …
Hair loss and regeneration performed on animal models.
Orasan MS, Roman II, Coneac A, Muresan A, Orasan RI. Orasan MS, et al. Clujul Med. 2016;89(3):327-34. doi: 10.15386/cjmed-583. Epub 2016 Jul 28. Clujul Med. 2016. PMID: 27547051 Free PMC article. Review.
Research in the field of reversal hair loss remains a challenging subject. As Minoxidil 2% or 5% and Finasteride are so far the only FDA approved topical treatments for inducing hair regrowth, research is necessary in order to improve therapeutical approach in al …
Research in the field of reversal hair loss remains a challenging subject. As Minoxidil 2% or 5% and Finasteride are so far th …
A Critical Assessment of the Evidence for Low-Level Laser Therapy in the Treatment of Hair Loss.
Gupta AK, Foley KA. Gupta AK, et al. Dermatol Surg. 2017 Feb;43(2):188-197. doi: 10.1097/DSS.0000000000000904. Dermatol Surg. 2017. PMID: 27618394 Review.
Data comparison across LLLT trials and with traditional hair loss therapy (minoxidil, finasteride) was not straight forward because there was a lack of visual evidence, sample sizes were low, and there were large variations in study duration and efficacy measurement …
Data comparison across LLLT trials and with traditional hair loss therapy (minoxidil, finasteride) was not straight forward be …
20 results